Adaptive Biotechnologies COO Disposes $1.01M in Stock, Exercises Options Worth $518K
Adaptive Biotechnologies Corp COO Julie Rubinstein sold 69,061 shares of common stock for roughly $1.01 million and concurrently exercised options to acquire 56,047 shares worth about $517,879 between April 17 and April 21, 2026. All moves were carried out under a Rule 10b5-1 trading plan adopted November 18, 2025. The transactions occurred as ADPT…